Related Experiment Video

Updated: Aug 17, 2026

A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments
07:30

A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments

Published on: November 9, 2017

Guillain-Barré syndrome in childhood

Monique M Ryan1

  • 1Institute for Neuromuscular Research and Discipline of Paediatrics and Child Health, University of Sydney, The Children's Hospital at Westmead, Westmead, New South Wales, Australia. moniquer@chw.edu.au

Journal of Paediatrics and Child Health
|June 15, 2005
PubMed

Insights

Guillain-Barré syndrome (GBS) causes acute flaccid paralysis in children. Identifying GBS subtypes aids in understanding causes and predicting outcomes for this rare neurological disorder.

Area of Science:

  • Neurology
  • Pediatrics
  • Immunology

Background:

  • Guillain-Barré syndrome (GBS) is a critical neurological condition.
  • It presents as acute, progressive, symmetric muscle weakness and reduced reflexes.
  • GBS is the leading cause of acute flaccid paralysis in children.

Purpose of the Study:

  • To summarize recent advancements in understanding Guillain-Barré syndrome.
  • To highlight the significance of identifying clinical and neurophysiological subtypes.
  • To improve the characterization of GBS etiology and prognostication.

Main Methods:

  • Review of recent clinical and neurophysiological research on GBS.
  • Analysis of subtype identification in Guillain-Barré syndrome.
  • Correlation of subtypes with etiological factors and patient outcomes.

Main Results:

  • Advances include the identification of distinct clinical and neurophysiological GBS subtypes.
  • These subtypes allow for more precise characterization of the disorder's origins.
  • Improved prognostication is achievable through subtype classification.

Conclusions:

  • Subtyping Guillain-Barré syndrome is crucial for advancing research.
  • Understanding subtypes enhances etiological insights and prognostic accuracy.
  • This approach benefits the management and study of pediatric GBS.

More Related Videos

Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation08:04

Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation

Published on: July 9, 2014

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-409:29

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4

Published on: August 21, 2017

Related Concept Videos

Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...